Our Current Trials

Condition	Trial Name	Sponsor
Rectal Cancer	19-288: Neoadjuvant TSR-042 (dostarlimab) for Patients with Rectal Adenocarcinoma	Memorial Sloan Kettering Cancer Center
Solid Tumors	ACE-Pan tumor-01: Antibody-Drug Conjugate ARX788 For Patients With HER2 Expressing Metastatic Solid Tumors	Ambrx, Inc.
Breast Cancer	ASCENT-03: Sacituzumab Govitecan as First Line Treatment for Patients With Triple Negative Breast Cancer	Gilead Sciences
Breast Cancer	ASCENT-04: Sacituzumab Govitecan in Combination With Pembrolizumab as First Line Treatment for Patients With PD-L1 Expressing Triple Negative Breast Cancer	Gilead Sciences
Non-Small Cell Lung Cancer	AdvanTIG-205: Ociperlimab and Tislelizumab as First-Line Treatment in the Metastatic Setting	BeiGene, Ltd.
Colon or Rectal Adenocarcinoma	BREAKWATER: First Line Encorafenib + Cetuximab +/- Chemotherapy in Patients Whose Tumors Express a BRAF V600E mutation	Pfizer
Breast Cancer	CDK2/4/6 Inhibitor RGT-419B in HR-Positive, HER2-Negative Metastatic Breast Cancer	Regor Pharmaceuticals, Inc.
Solid Tumor or Lymphoma	CS5001-101: A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas	CStone Pharmaceuticals
Chemotherapy-Induced Oral Mucositis	Chemo Mouthpiece Medical Device Trial	Chemo Mouthpiece, LLC
Colon or Rectal Cancer	GO-010: Neoantigen Vaccine GRT-C901/GRT-R902 as Maintenance After First Line Metastatic Therapy	Gritstone bio, Inc.
Head and Neck Squamous Cell Carcinoma	GS-US-548-5916: Magrolimab Combinations in Recurrent or Metastatic HNSCC	Gilead Sciences, Inc.
Colon or Rectal Cancer	KRYSTAL-10: Adagrasib in KRAS G12C Mutated Colorectal Cancer	Mirati Therapeutics, Inc.
Diffuse Large B-Cell Lymphoma	LOTIS-9: Loncastuximab Tesirine and Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Patients	ADC Therapeutics SA
Colon or Rectal Cancer	LUT014 Gel for EGFR-Inhibitor Induced Acneiform Rash	Lutris Pharma Ltd.
Non-Hodgkin Lymphoma	MorningSun: Mosunetuzumab Monotherapy in Participants With Select B-Cell Malignancies	Genentech, Inc.
Hyperkalemia/Chronic Kidney Disease	NYH-01: Hyperkalemia/Chronic Kidney Disease	Relypsa
Solid Tumors	OnTARGET: Crofelemer for Diarrhea Prophylaxis in Patients Receiving Targeted Therapy	Napo Pharmaceuticals
Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome	PRT1419-03: PRT1419 in Patients with Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndrome	Prelude Therapeutics
Oropharyngeal Cancer	VOICE: Clonidine Mucoadhesive Buccal Tablet for Chemoradiotherapy-Induced Oral Mucositis	Monopar Therapeutics Inc.
Non-Small Cell Lung Cancer, Colorectal Cancer, Melanoma	[Registry] BESPOKE IO: Study of ctDNA Guided Immunotherapy	Natera, Inc.
Breast Cancer	[Registry] Liquid vs Tissue Biopsy Concordance in Samples of 1st Suspected Breast Cancer Recurrence & Metastasis	Epic Sciences
Cancer Diagnosis	[Registry] MSK-IMPACT/ACCESS Genomic Profiling in Cancer Patients	Memorial Sloan Kettering Cancer Center
Prostate Cancer	[Registry] Trial Evaluating the RadTox Assay for Predicting GI Toxicity Associated with Radiation Therapy	DiaCarta, Inc.
Solid Tumors	[Sample Collection] A Prospective Blood Sample Collection Study to Evaluate a Panel of Protein-based Biomarkers (SEERPRO)	Seer, Inc.
Various Indications	[Sample Collection] Clinical Biospecimen Procurement Protocol to Support Advancements in Medical Diagnoses of Diseases (PROMEDx)	Precision for Medicine
Solid Tumors	[Sample Collection] Collection and Distribution of Biofluids for Research Purposes	Bluestar Genomics
Solid Tumors	[Sample Collection] Detecting cancers Earlier Through Elective plasma-based Cancer SEEK Testing (DETECT-ASCEND 2)	Exact Sciences Thrive LLC
Various Indications	[Sample Collection] Discovery and Evaluation of Biomarkers/Pharmacogenomics for the Diagnosis and Personalized Management of Patients (MTG-022)	MT Group
Various Indications	[Sample Collection] Prospective Collection of Samples for Research (SERATRIALS-05035)	SERATRIALS, LLC.
Solid Tumors	[Sample Collection] Vallania: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening	Freenome Holdings Inc.

Our Current Trials

Call Us

COVID-19 - Information